Cross Country Healthcare Inc. reported third quarter 2025 revenue of $250.1 million, representing a 21.0% decrease compared to the third quarter of 2024 and a 9.0% decrease from the previous quarter. Gross profit margin was 20.4%. The company recorded a net loss attributable to common stockholders of $4.8 million, with diluted earnings per share at negative $0.15. Adjusted EBITDA was $6.5 million, a 37.0% decline year-over-year and a 14.0% decrease quarter-over-quarter, with an adjusted EBITDA margin of 2.6%. Adjusted earnings per share stood at $0.03. Cash flows provided by operations totaled $20.1 million for the quarter. Business developments included strong performance in Homecare Staffing, with revenue in this segment increasing by more than 29.0% over the prior year, and a continued sequential decline in selling, general and administrative expenses, partly due to increased leverage of the company's low-cost center of excellence in India. The company reported a cash balance of $99 million and no debt as of September 30, 2025. Pending a merger with Aya, Cross Country Healthcare did not provide forward-looking guidance or host an earnings conference call.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cross Country Healthcare Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251111265320) on November 12, 2025, and is solely responsible for the information contained therein.
Comments